Sanofi is the first influenza vaccine manufacturer to receive licensure for its 2012-2013 flu vaccine formulations. In mid-July, the company began accepting orders for this year's vaccine formulations online through VaccineShoppe.com. The company expects to deliver more than 50% of the reserved doses by the end of August.
In its drive to further increase vaccination rates all over the country, Sanofi Pasteur has also launched a national Direct-to-Consumer advertising campaign for the FLUZONE® Intradermal Vaccine. The new vaccine system utilizes a microinjection needle to deliver the vaccine, and has a 90% smaller needle compared to the conventional intra-muscular injections.
MainStreet Vaccine members enrolled in the Sanofi Pasteur contract can take advantage of the company's FLUZONE Reservation Pricing Promotion to maximize their savings when ordering their supply.
For complete product information and preferential pricing for Main Street Vaccines members enrolled in the Sanofi Pasteur contract, visit http://www.mainstreetvacs.com/
About Main Street Vaccines:
Main Street Vaccines is a national physician purchasing group with over 7,000 member physicians and medical practices all over the country. Members are eligible for special pricing and rebates on Sanofi Pasteur flu vaccines, including the FLUZONE® Intradermal vaccine. For more information call 888-482-6246 (888-HUB-MAIN)
